BiotechTube
Home/Passage Bio/Simona King
SK

Simona King

Chief Financial Officer

Passage Bio

Therapeutic Areas

NeurologyRare Diseases

Passage Bio Pipeline

DrugIndicationPhase
PBFT02Frontotemporal Dementia with progranulin mutations (FTD-GRN)Phase 1/2
PBGM01Infantile GM1 GangliosidosisPhase 1/2

Leadership Team at Passage Bio

BG
Bruce Goldsmith
President and Chief Executive Officer
ES
Eliseo Salinas
Former Chief Executive Officer
WC
William Chou
Chief Executive Officer
RM
Richard Morris
General Counsel
View full Passage Bio profile